Loading clinical trials...
Loading clinical trials...
Phase II Clinical Trial of HSV G207 With a Single 5 Gy Radiation Dose in Children With Recurrent High-Grade Glioma
Conditions
Interventions
Biological G207
Locations
5
United States
Holly Lindsay MD
Aurora, Colorado, United States
Memorial Sloan Kettering
New York, New York, United States
UPMC Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States
MD Anderson Cancer Center
Houston, Texas, United States
Texas Children's Hospital
Houston, Texas, United States
Start Date
September 1, 2025
Primary Completion Date
December 18, 2025
Completion Date
December 18, 2025
Last Updated
February 10, 2026
NCT03206060
NCT06608446
NCT07541924
NCT07542041
NCT04389632
NCT03340506
Lead Sponsor
Pediatric Brain Tumor Consortium
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions